Lataa...
Agonist antibodies for cancer immunotherapy: History, Hopes and Challenges
Immunotherapy is amongst the most promising new treatment modalities to arise over the last two decades; antibody drugs are delivering immunotherapy to millions of patients with many different types of cancer. Initial success with antibody therapeutics came in the form of direct targeting or cytotox...
Tallennettuna:
| Julkaisussa: | Clin Cancer Res |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2024
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7615925/ https://ncbi.nlm.nih.gov/pubmed/38153346 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-23-1014 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|